Abiopharma

Zimmer Biomet Holdings, Inc. Notification

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

XOMA Royalty Declares Quarterly Preferred Stock Dividends

AGA Precision Systems LLC Achieves Globally Recognized AS9100 Certification for Aerospace, Defense, and Space Manufacturing, Exploring Future Humanoid Robotics Integration

Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Incyte Japan maakt de goedkeuring bekend van Minjuvi® (tafasitamab) in combinatie met rituximab en lenalidomide voor de behandeling van gerecidiveerd of refractair folliculair lymfoom

Incyte Japón anuncia la aprobación de Zynyz® (retifanlimab) para el tratamiento de primera línea del cáncer anal avanzado.

Incyte Japan annuncia lapprovazione di Zynyz® (retifanlimab) per il trattamento di prima linea del cancro anale in fase avanzata